Clinical Trials Watch
Indian Journal of Medical Ethics | Vol 7, No 2 | 2010 Read full article Continue reading
Category: Clinical Trials
Glad you asked: Participants’ Opinions of Re-Consent for dbGaP Data Submission
Ludman, E. J., Fullerton, S. M., Spangler, L., Trinidad, S. B., Fujii, M. M., Jarvik, G. P.,Burke, W. | Journal of Empirical Research on Human Research Ethics | September 2010 | NIH Public Access No consensus exists about when researchers… Continue reading
Communicating Disclosure Risk in Informed Consent Statements
Singer, E., & Couper, M. P. | Journal of Empirical Research on Human Research Ethics | September 2010 | NIH Public Access For several years, we have experimented with various ways of communicating disclosure risk and harm to respondents in… Continue reading
Pragmatic problems with clinical equipoise
Kowalski C. J. | PubMed | 2010 Spring;53(2):161-73 It is widely accepted that if one is to follow the ethical tenets of clinical equipoise, phase III controlled clinical trials must be designed pragmatically, to measure effectiveness rather than efficacy. This choice… Continue reading
Human Subject Protection In India – Is It Adequate?
Dr. Narges Mahaluxmivala | Perspectives in Clinical Research | 2010 Jan-Mar | 1(1) | Source: NCBI-PMC Abstract India′s experience in clinical trials is shorter in time than that of the developed countries but as in everything else in the current… Continue reading
Fatal trials: clinical trials are killing people
Amit Sengupta | Indian Journal of Medical Ethics | Vol 6, No. 3 | 2009 In many quarters there is satisfaction that India is developing into the “clinical trials capital” of the globe. By all accounts the business of conducting… Continue reading